MedPath

BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987517)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02803008

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY 987517)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02803099

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987516)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
15
Registration Number
NCT02803034

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987517)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
10
Registration Number
NCT02803021

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987516)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
11
Registration Number
NCT02803047

To Evaluate Eye Installation-Tear Free

Not Applicable
Completed
Conditions
Sunscreening Agents
Interventions
Drug: SPF 50 X15 158 (BAY 987516)
Drug: SPF 50 X57 162 (BAY 987516)
Drug: SPF 50 Y49 091 (BAY 987516)
Drug: SPF 50 X15 160 (BAY 987516)
Other: J & J baby shampoo, X46 046 (control)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
83
Registration Number
NCT02802917

Sun Protection Factor Assay

Not Applicable
Completed
Conditions
Sunscreening Agent
Interventions
Drug: Coppertone (BAY987516)
First Posted Date
2016-06-16
Last Posted Date
2018-12-12
Lead Sponsor
Bayer
Target Recruit Count
15
Registration Number
NCT02803060

Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

Phase 3
Completed
Conditions
Metastatic Hormone-sensitive Prostate Cancer
Interventions
Drug: Standard ADT (androgen deprivation therapy)
Drug: BAY1841788 / darolutamide (ODM-201)
Drug: Placebo
Drug: Docetaxel
First Posted Date
2016-06-15
Last Posted Date
2024-04-16
Lead Sponsor
Bayer
Target Recruit Count
1306
Registration Number
NCT02799602

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO

Phase 4
Completed
Conditions
Central Retinal Vein Occlusion
Interventions
First Posted Date
2016-06-15
Last Posted Date
2020-07-08
Lead Sponsor
Bayer
Target Recruit Count
162
Registration Number
NCT02800642

Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

Completed
Conditions
Prostatic Neoplasms
Interventions
Other: Not applicable for study
First Posted Date
2016-06-02
Last Posted Date
2019-05-08
Lead Sponsor
Bayer
Target Recruit Count
2234
Registration Number
NCT02788409
© Copyright 2025. All Rights Reserved by MedPath